The Drug Discovery Innovation Programme (DDIP) Europe 2026 is a leading Drug Discovery Conference focused on accelerating pharmaceutical research and development across the European life sciences ecosystem. Hosted in Basel, this high-level programme convenes senior scientists, pharma and biotech leaders, healthcare innovators, and solution providers to exchange insights that shape modern drug discovery and development.
DDIP Europe advances drug discovery through integrated science, advanced technologies, and cross-border collaboration for smarter development.
We support a collaborative drug discovery ecosystem powered by AI and data-driven research to improve patient outcomes.
DDIP Europe serves as a strategic B2B platform that brings together industry leaders, researchers, and solution providers to exchange knowledge, foster collaboration, and build meaningful partnerships across drug discovery and pharmaceutical development.
The Drug Discovery Innovation Programme Europe 2026 is a leading Drug Discovery Conference driving insight, collaboration, and measurable scientific and commercial impact.
Engage with senior leaders sharing practical strategies, real-world case studies, and data-driven insights shaping drug discovery.
Connect through curated meetings with pharma executives, biotech innovators, investors, and research leaders across Europe.
Discover next-generation platforms and AI-driven solutions accelerating drug discovery and development pipelines.
Identify collaboration opportunities supporting faster research, smarter development, and scalable innovation across drug discovery.
Join a global community advancing responsible innovation, scientific excellence, and lasting impact in pharmaceutical research.
Top Executives, Scientists, and Researchers from Leading Pharmaceutical and Biotech Companies, Research Institutions, Regulatory Agencies, and Investment Firms.
